IP Library Granted Patent US 8,323,723
Granted Patent B2
US 8,323,723 · App. 13/107,243 · Granted Dec 4, 2012

Controlled vapor deposition of biocompatible coatings for medical devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,323,723
App. No.
13/107,243
Granted
Dec 4, 2012
Kind
B2
Abstract

An intraocular lens with a hydrophilic polymer coating composition and method of preparing same are provided. Specifically, a composition suitable for reducing tackiness in intraocular lenses is provided wherein an acrylic intraocular lens is treated by vapor deposition with an alkoxy silyl terminated polyethylene glycol polymer composition.

Claims (12)

1. A method for providing an intraocular lens surface with a hydrophilic polymer coating comprising:

applying at least one hydrophilic polymer coating to at least one surface of said intraocular lens using vapor deposition,

wherein the vapor deposition comprises the steps of:

a) exposing a surface of the intraocular lens to an oxygen-comprising plasma in a processing chamber which is at subatmospheric pressure;

b) subsequently, without exposure of said oxygen-comprising plasma treated surface to ambient conditions which contaminate or react with said plasma treated surface, exposing said surface to a silicon chloride containing vapor in the presence of moisture, to form a hydrophilic silicon oxide layer on said surface; and

c) subsequently, without exposure of said hydrophilic silicon oxide layer to ambient conditions which contaminate or react with said hydrophilic silicon oxide layer, exposing said silicon oxide layer to a polyethylene glycol polymer having a plurality of monomers to form a layer selected from the group consisting of a monolayer, a self-aligned monolayer, and a polymerized cross-linked layer, wherein of the monomers have a structure of Formula 1:

wherein R 1 , R 2 and R 3 can be, individually a chlorine or a methoxy group;

x is 3;

y is an integer from 6 to 9; and

R′ is a methoxy.

2. The method according to claim 1 wherein R 1 , R 2 and R 3 all comprise methoxy groups.

3. The method according to claim 1 wherein said monomer has the structure of Formula 2:

Assignments (1)
CHANGE OF NAME Recorded Sep 25, 2018
From: ABBOTT MEDICAL OPTICS INC.
To: JOHNSON & JOHNSON SURGICAL VISION, INC.
Reel/Frame 047151/0187 →